According to Straits Research, the global bronchoscopes market size was valued at USD 3.46 billion in 2025 and is projected to increase from USD 3.80 billion in 2026 to USD 8.03 billion by 2034, registering a CAGR of 9.8% during the forecast period (2026–2034). North America dominated the global market with a 38.4% share in 2025, while Asia Pacific is anticipated to register the fastest CAGR of 10.46%.
Bronchoscopes are specialized medical instruments used to examine the airways and lungs, collect tissue samples, and perform minimally invasive respiratory procedures. Flexible and rigid devices support the diagnosis and treatment of conditions such as lung cancer, pneumonia, and airway obstructions. Advancements in robotic navigation, artificial intelligence, and imaging technologies are strengthening their role in pulmonary healthcare.
Market Size (2025): USD 3.46 Billion
Market Size (2026): USD 3.80 Billion
CAGR (2026–2034): 9.8%
Forecast Year: 2034
Projected Market Size (2034): USD 8.03 Billion
Dominant Region: North America
Fastest-Growing Region: Asia Pacific
The bronchoscopes industry is benefiting from the clinical need for early lung cancer diagnosis and minimally invasive respiratory procedures. Healthcare providers use bronchoscopes for airway examinations, biopsies, secretion removal, and other diagnostic and therapeutic interventions. The high incidence of respiratory diseases is supporting equipment procurement across hospitals and specialized pulmonary care facilities.
The development of intensive care and emergency respiratory services is another important growth factor. Bronchoscopes assist medical professionals in managing airway obstructions, collecting respiratory samples, and treating critically ill patients. Advancements in flexible and portable systems are also strengthening their clinical applications.
High equipment costs, maintenance requirements, and the need for specialized healthcare professionals can restrict the adoption of advanced bronchoscopic systems. Reusable devices also require thorough cleaning and sterilization, creating additional operational responsibilities for healthcare facilities.
However, disposable bronchoscopes, robotic-assisted procedures, and AI-powered lesion detection present significant business opportunities. Manufacturers can strengthen revenue streams through single-use instruments, advanced imaging systems, compatible accessories, and navigation technologies designed for peripheral lung biopsies.
By product, flexible bronchoscopes are projected to register a CAGR of 9.16%, supported by their versatility in diagnostic and therapeutic respiratory procedures. Rigid bronchoscopes are anticipated to record a CAGR of 6.84%.
By usage, disposable bronchoscopes are expected to register the fastest CAGR of 11.24%, reflecting healthcare providers' focus on infection prevention and cross-contamination control. Reusable devices are projected to record a CAGR of 7.28%.
By application, oncology dominated with a 31.6% share in 2025, while ICU airway management is projected to register the fastest CAGR of 9.42%. By end user, hospitals led with a 68.5% share, whereas ambulatory surgical centers are anticipated to record the fastest CAGR of 9.67%.
North America dominated the global market with a 38.4% share in 2025, reaching USD 1.33 billion. The U.S. is projected to record approximately 229,410 new lung and bronchus cancer cases in 2026, supporting the need for pulmonary diagnostic procedures. Canada's projected 32,900 new cases in the same year also highlight the importance of specialized respiratory care.
Asia Pacific accounted for 22.8% of the global market, reaching USD 0.79 billion, and is projected to register the fastest CAGR of 10.46%. Japan's aging population, China's chronic respiratory disease prevention initiatives, and India's tuberculosis screening activities are supporting the development of pulmonary diagnostic services.
Europe represented 27.6% of the global market in 2025, reaching USD 0.95 billion. The U.K.'s national lung cancer screening rollout and Germany's annual low-dose CT screening coverage for eligible high-risk individuals are strengthening the need for diagnostic follow-up procedures, including bronchoscopy.
The competitive landscape includes medical device manufacturers focusing on flexible endoscopes, robotic bronchoscopy platforms, disposable instruments, and advanced imaging technologies. Key industry participants include:
Olympus Corporation
Boston Scientific Corporation
Ambu A/S
KARL STORZ SE & Co. KG
FUJIFILM Holdings Corporation
Medtronic plc
Cook Medical LLC
Teleflex Incorporated
Intuitive Surgical, Inc.
Richard Wolf GmbH
Technological advancements in robotic bronchoscopy and AI-assisted navigation are transforming pulmonary diagnostic procedures. Intuitive Surgical's Ion endoluminal system demonstrates the application of advanced navigation technology for accessing peripheral lung lesions and supporting minimally invasive biopsies.
Cone-beam CT integration and real-time 3D imaging are also gaining attention for their ability to improve lesion localization and confirm instrument positioning during bronchoscopic procedures. These developments are encouraging manufacturers to strengthen imaging capabilities and procedural accuracy.
The global bronchoscopes industry is expected to benefit from advancements in robotic navigation, flexible endoscopy, disposable instruments, and AI-assisted diagnostics. The clinical focus on early lung cancer detection, infection prevention, and intensive care airway management is likely to support equipment procurement. Manufacturers investing in advanced imaging, single-use devices, and user-friendly bronchoscopic systems are positioned to capture emerging opportunities through 2034.
Click to Download and Read the Full Report:https://straitsresearch.com/report/bronchoscopes-market
Straits Research is a global market intelligence and consulting company providing comprehensive market research, industry analysis, and strategic business insights. The company delivers data-driven reports, competitive assessments, and actionable intelligence that help organizations understand market developments, identify emerging opportunities, and make informed business decisions.